Ribomic Inc.

Informe acción TSE:4591

Capitalización de mercado: JP¥3.3b

Ribomic Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Ribomic's earnings have been declining at an average annual rate of -9.2%, while the Biotechs industry saw earnings growing at 10.5% annually. Revenues have been declining at an average rate of 8% per year.

Información clave

-9.2%

Tasa de crecimiento de los beneficios

6.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Biotechs 31.9%
Tasa de crecimiento de los ingresos-8.0%
Rentabilidad financiera-29.8%
Margen neto-94,400.0%
Próxima actualización de resultados12 Nov 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Companies Like Ribomic (TSE:4591) Are In A Position To Invest In Growth

Oct 30
Companies Like Ribomic (TSE:4591) Are In A Position To Invest In Growth

We're Not Very Worried About Ribomic's (TSE:4591) Cash Burn Rate

Jul 02
We're Not Very Worried About Ribomic's (TSE:4591) Cash Burn Rate

Desglose de ingresos y gastos

Cómo gana y gasta dinero Ribomic. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

TSE:4591 Ingresos, gastos y beneficios (JPY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 241-944349687
31 Mar 240-1,024352764
31 Dec 2362-979350816
30 Sep 2362-1,3293771,126
30 Jun 2363-1,3743671,189
31 Mar 2365-1,6533611,491
31 Dec 2276-2,0463311,846
30 Sep 2278-1,7953241,618
30 Jun 2280-1,9613241,767
31 Mar 2280-1,6843131,482
31 Dec 2193-1,4482821,268
30 Sep 2192-1,3662701,207
30 Jun 2191-1,2552861,049
31 Mar 2191-1,187304957
31 Dec 20121-1,056337839
30 Sep 20122-1,044332823
30 Jun 20122-903325710
31 Mar 20121-855319673
31 Dec 1912-804342580
30 Sep 1910-761332543
30 Jun 198-779327562
31 Mar 197-836322612
31 Dec 1814-919324748
30 Sep 1830-904315759
30 Jun 1847-867307746
31 Mar 1864-753300663
31 Dec 1768-714285604
30 Sep 1777-700283621
30 Jun 1786-661282599
31 Mar 1793-646268610
31 Dec 16101-459254521
30 Sep 16103-393241453
30 Jun 16106-371225455
31 Mar 16121-323219435
31 Dec 15149-365217334
30 Sep 15173-317213313
30 Jun 15197-286213291
31 Mar 1547910191282
31 Mar 14151-211146418

Ingresos de calidad: 4591 is currently unprofitable.

Margen de beneficios creciente: 4591 is currently unprofitable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 4591 is unprofitable, and losses have increased over the past 5 years at a rate of 9.2% per year.

Acelerando crecimiento: Unable to compare 4591's earnings growth over the past year to its 5-year average as it is currently unprofitable

Beneficios vs. Industria: 4591 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (4%).


Rentabilidad financiera

Alta ROE: 4591 has a negative Return on Equity (-29.75%), as it is currently unprofitable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado